GLP-1R agonist Treatment of Bscl2-null Mouse model of CGL2
收藏DataCite Commons2024-02-22 更新2024-07-13 收录
下载链接：
https://abdn.elsevierpure.com/en/datasets/aef8fe2e-5180-4693-b187-750dfecf5e9e
下载链接
链接失效反馈官方服务：
资源简介：
Data resulting from studying the potential therapeutic benefits of GLP-1R agonists (here liraglutide) in lipoatrophic diabetes. Here Seipin-deficient Bscl2 null mice, modelling Congenital Generalised Lipodystrophy Type 2 (CGL2) were treated acutely or for 14 days with liraglutide. Assessments of glucose tolerance, insulin tolerance, pyruvate tolerance were made as well as determination of changes to hepatic steatosis, insulin secretion, pancreas histology and appetite regulation.
提供机构：
University of Aberdeen
创建时间：
2024-02-22
